To determine which of these genes may be direct FoxP1 targets in the context of tumor burden, we overlapped FoxP1-dependent DEGs at each time point from our circadian RNA-seq dataset with genes showing FoxP1 binding within their promoter region as determined by ChIP-seq (Figure S1; Table S5). The gene discussed is FOXP1; the disease is neoplasm.